Burning Rock Biotech Ltd SEC filings BNR
Burning Rock Biotech Ltd has 169 filings in SEC EDGAR's recent list, going back to Nov 4, 2019. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Apr 28, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2025 | Dec 31, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Nov 26, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 20, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 23, 2021 | Dec 31, 2020 |
Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BNR (Nasdaq)
- Headquarters
- Guangzhou, Guangdong
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1792267
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.